Faricimab Injection [Vabysmo]
Faricimab Injection [Vabysmo] is a pharmaceutical drug with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome
Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy
Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Clinical Trials (8)
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome
Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy
Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration
Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8